Please login to the form below
10
Revenue 2017Amgen
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Amgen's 2013 sales performance.
Amarin hits jackpot with astonishing heart benefits from fish oil product
Achieving a reduction of 25% in major adverse CV events (MACE) is an uncommon achievement (though Amgen's Repatha achieved a similar effect) but the product's relatively low cost and
Teva wins FDA OK for crucial migraine drug
Teva wins FDA OK for crucial migraine drug. Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig. ... 900 before rebates and discounts – exactly the same level as Novartis and Amgen positioned Aimovig, and in line with stablished
Boehringer bolts on another immuno-oncology company
Oncolytic virus-based therapies are consistent with and complement that strategy.”. The first oncolytic virus therapy to reach western markets was Amgen’s Imlygic (talimogene laherparepvec or T-Vec) which was
Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline
It is struggling to compete with Amgen’s Repatha, earning just $73m in the second quarter compared to its rival’s $148m.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Associate Scientific Director
-
Salary TBC
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
- Account Director or Senior Account Director
-
Salary TBC
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Senior Medical Writer
-
Salary is DOE
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Account Director - Digital
-
Great salary and benefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Account Manager
-
Negotiable
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Systematic Review Lead- London
-
Negotiable
Subscribe to our email news alerts
- Novartis cuts manufacturing jobs in Switzerland and UK
- Bluebird’s first gene therapy gets European fast track
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- After Lucentis setback, Novartis trumpets data on follow-up drug
- J&J files ‘breakthrough’ bladder cancer drug in US
PMHub
Havas Life Medicom
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...
Latest intelligence
- Congress Effectiveness Management
- Maximising the ROI of scientific meetings...
- Biopharma's Future: Made in China
- The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
- Solaris Health looks at the gene therapy revolution
- Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
Quick links
Infographics
